Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema

Acta Ophthalmologica

Volumn 86, Issue 4, 2008, Pages 377-384

  Shimura, Masahiko ^a   Nakazawa, Toru ^b   Yasuda, Kanako ^a   Kunikata, Hiroshi ^b   Shiono, Takashi ^c   Nishida, Kohji ^b  

^a NTT East Tohoku Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shiono Eye Center   (Japan)

Author keywords

Branch retinal vein occlusion (BRVO); Cytokine; Macular oedema; Visual prognosis; Vitrectomy

Indexed keywords

CYTOKINE; INTERLEUKIN 6; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OPTICAL COHERENCE TOMOGRAPHY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RETINA FOVEA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SCORING SYSTEM; SURGICAL TECHNIQUE; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY; CLINICAL TRIAL; CONNECTIVE TISSUE; DECOMPRESSION SURGERY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RETINA VEIN; TREATMENT OUTCOME; VISUAL DISORDER;

AGED; CONNECTIVE TISSUE; DECOMPRESSION, SURGICAL; FEMALE; FOVEA CENTRALIS; HUMANS; INTERLEUKIN-6; MACULAR EDEMA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETINAL VEIN; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION, LOW; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 47649101872     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.01074.x     Document Type: Article

References (29)

1. Amirikia A, Scott IU, Murray TG, Flynn HW Jr, Smiddy WE & Feuer WJ (2001): Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 108: 372-376.
2. Branch Vein Occlusion Study Group (1984): Argon laser photocoagulation for macular oedema in branch vein occlusion. Am J Ophthalmol 98: 271-282.
3. Butler JM, Guthrie SM, Koc M et al. (2005): SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115: 86-93.
4. Cohen T, Nahari D, Cerem LW, Neufeld G & Levi BZ (1996): Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736-741.
5. Desai TR, Leeper NJ, Hynes KL & Gewertz BL (2002): Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 104: 118-123.
6. Er H, Doganay S, Turkoz Y, Cekmen M, Daglioglu MC, Gunduz A, Evereklioglu C & Isci N (2000): The vitreous levels of cytokines and nitric oxide in rabbit vitreous humour after retinal laser photocoagulation. Ophthalmic Surg Lasers 31: 479-483.
7. Ferrara N, Gerber HP & LeCouter J (2003): The biology of VEGF and its receptors. Nat Med 9: 669-676.
8. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S & Hori S (2003): Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular oedema. Ophthalmology 110: 1690-1696.
9. Garcia-Ramirez M, Canals F, Hernandez C, Colome N, Ferrer C, Carrasco E, Garcia-Arumi J & Simo R (2007): Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): A new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 50: 1294-1303.
10. Gardner TW, Antonetti DA, Barber AJ, Lieth E & Tarbell JA (1999): The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol 97: 229-237.
11. Hayreh SS, Zimmerman MB & Podhajsky P (1994): Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117: 429-441.
12. Hernandez C, Carrasco E, Garcia-Arumi J, Maria Sequra R & Simo R (2004): Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy. Diabetes Metab 30: 341-346.
13. Loeffler S, Fayard B, Weis J & Weissenberger J (2005): Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promotor activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115: 202-213.
14. Maruo N, Morita I, Shirao M & Murota S (1992): IL-6 increases endothelial permeability in vitro. Endocrinology 131: 710-714.
15. Mason J, Feist R, White M, Swanner J, McGwin G Jr & Emond T (2004): Sheathotomy to decompress branch retinal vein occlusion: A matched control study. Ophthalmology 111: 540-545.
16. Mester U & Dillinger P (2002): Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 22: 740-746.
17. Noma H, Funatsu H, Yamasaki M et al. (2005a): Pathogenesis of macular oedema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256-261.
18. Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H & Mishima HK (2005b): Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular oedema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309-315.
19. Ogata N, Ando A, Uyama M & Matsumura M (2001): Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 239: 87-95.
20. Opremcak EM & Bruce RA (1999): Surgical decompression of branch vein occlusion via arteriovenous crossing sheathotomy: A prospective review of 15 cases. Retina 19: 1-15.
21. Paques M, Massin P & Gaudric A (1997): Growth factors and diabetic retinopathy. Diabetes Metab 23: 125-130.
22. Ravalico G & Battaglia Parrodi M (1992): Exudative retinal detachment subsequent to retinal vein occlusion. Ophthalmologica 205: 77-82.
23. Saika S, Tanaka T, Miyamoto T & Ohnishi Y (2001): Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular oedema associated with branch retinal vein occlusion: Retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239: 729-732.
24. Shah GK, Sharma S, Fineman MS, Federman J, Brown MM & Brown GC (2000): Arteriovenous adventitial sheathotomy for the treatment of macular oedema associated with branch retinal vein occlusion. Am J Ophthalmol 129: 104-106.
25. Shweiki D, Itin A, Soffer D & Keshet E (1992): Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
26. Silva RM, Faria de Abreu JR & Cunha-Vaz JG (1995): Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol 233: 721-726.
27. Tachi N, Hashimoto Y & Ogino N (1999): Vitrectomy for macular oedema combined with retinal vein occlusion. Doc Ophthalmol 97: 465-469.
28. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N & Campochiaro PA (1997): Cellular mechanisms of blood-retinal barrier dysfunction in macular oedema. Doc Ophthalmol 97: 217-228.
29. Wallow IH, Danis RP, Bindley C & Neider M (1988): Cystoid macular degeneration in experimental branch retinal vein occlusion. Ophthalmology 95: 1371-1379.